Optimising artificial intelligence in the pharmaceutical industry

Artificial intelligence can be applied to almost every part of the pharma industry. Christopher Rafter discusses its many uses and how the adoption of machine learning will increase in the future. Artificial intelligence (AI) has wide-reaching potential within the pharmaceutical industry, from clinical trials to marketing and sales analytics. Using a machine learning programme can reduce the time spent on examining data, saving money and allowing researchers to focus on other issues. European Pharmaceutical Review's Victoria Rees spoke with Christopher Rafter, Chief Operating Officer (COO) of Inzata Analytics, to discover more about AI in pharma and its capabilities.